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CHARACTERIZAT ION OF MIXED ALLOGENEIC  CHIMERAS 
Imrnunocompetence,  In Vitro Reactivity, and Genetic Specificity of  
To lerance 
BY SUZANNE T. ILDSTAD, SHERRY M. WREN, JEFFREY A. BLUESTONE, 
SUSAN A. BARBIERI, AND DAVID H. SACHS 
From the Transplantation Biology Section, Immunology Branch, National Cancer Institute, 
National Institutes of Health, Bethesda, Maryland 20205 
To date, solid organ and bone marrow transplantation between genetically 
disparate individuals has depended upon nonspecific immunosuppressive agents 
to control chronic rejection. Although these agents are vital to suppression of 
graft rejection, they have their own associated toxicities, including susceptibility 
to opportunistic nfections, osteoporosis, impaired hepatic or renal function, and 
an increased incidence of neoplasms. Chronic rejection, in varying degrees of 
severity, often persists despite the use of these agents. 
Numerous methods have been attempted to induce specific transplantation 
tolerance. Experimental animal models have included neonatal bone marrow 
inoculation (1) and whole body irradiation, or fractionated total lymphoid irra- 
diation coincident with bone marrow transplantation a d immediate or deferred 
solid organ transplantation i  adult recipients (2-4). As a preparation for subse- 
quent organ allografts, these methods have the advantage of induction of specific, 
rather than nonspecific tolerance. However, bone marrow transplantation is
currently limited by graft-vs.-host disease (GVHD) 1 (5), and a level of immunoin- 
competence probably resulting from failure of appropriate immune cell interac- 
tions in the reconstituted host (6-8). We have attempted to overcome these 
limitations in the murine system by reconstituting the lethally irradiated host 
with T cell-depleted syngeneic plus allogeneic bone marrow components (9). 
Such animals were specifically tolerant to donor-type, full-thickness tail skin 
grafts, and exhibited stable hematopoietic chimerism. In addition, survival rates 
were excellent, with no evidence for GVHD or wasting. 
We have presumed that such mixed reconstituted animals are superior to fully 
allogeneic himeras because the presence of the syngeneic omponents over- 
comes the immunoincompetence that results from restriction of immune cell 
interactions in fully ailogeneic himeras, while the allogeneic elements provide 
conditioning for induction of specific tolerance. We have now examined in detail 
patterns of reconstitution, immunocompetence, and in vitro reactivity of such 
l Abbreviations u ed in this paper: CML. cell-mediated lympholysis; Con A, concanavalin A; FITC 
fluorescein sothiocyanate; GVHD, graft-vs.-host disease; MEM, minimum essential medium; MHC, 
major histocompatibility complex; MLR, mixed lymphocyte r action; MST, median survival time; 
PBL, peripheral blood lymphocyte; PFC, plaque-forming cell; RAMB, rabbit anti-mouse brain; 
SRBC, sheep red blood cell. 
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mixed allogeneically reconstituted animals. In addition, we have extended this 
model to a major histocompatibility complex (MHC)-disparate, noncongenic 
model to assess the influence of minor antigens on induction and maintenance 
of tolerance to hematopoietic cells and allogeneic tissues. The mixed allogeneic 
system offers a model for investigation of mechanisms of induction and mainte- 
nance of transplantation tolerance in the adult animal, with potential application 
to the human clinical setting. 
Materials and  Methods  
Animals. 6-8-wk-old male C57BL/10Sn (B10), B10.BR, B10.D2, and C3H/HeJ mice 
were obtained from The Jackson Laboratory, Bar Harbor, ME. Animals were housed in 
a specific pathogen-free facility at the National Institutes of Health. 
Mixed Allogeneic Reconstitutions (BIO + BIO.D2 --~ BIO). Mixed allogeneic himeras 
were prepared by a modification of the methods previously described (10). Briefly, inbred 
B10 male recipients were lethally irradiated with 950 rad from a z37Cs ource. Using 
sterile technique, bone marrow was flushed from the femurs and tibias of B10, B 10.D2, 
B10.BR, and C3H/HeJ male mice with Media 199 (Gibco, Grand Island, NY) containing 
50 ~l/ml of gentamicin (MEM) using a 23-gauge needle. The marrow was mechanically 
resuspended in MEM by gentle aspiration through a 19-gauge needle, and the suspension 
was sterilely filtered through nylon mesh. The cells were then centrifuged to a pellet at 
1,200 rpm for 10 min, resuspended in MEM, and counted. Bone marrow was T cell- 
depleted by treatment with a 1:60 dilution of rabbit anti-mouse brain (RAMB) (at a ratio 
of l0 s cells per milliliter of RAMB) sera at 4°C for 30 rain, as previously described (9). 
The cells were subsequently washed and resuspended in sterile filtered guinea pig 
complement (Gibco) at a 1:3 dilution in MEM (10 s cells/ml) at 37°C for 30 rain. Ceils 
were then washed twice (1,200 rpm for 10 rain) and resuspended in MEM at the 
concentration appropriate to allow injection of 1 ml final volume per animal. Recipient 
animals were reconstituted 4-6 h after lethal irradiation via injection of cells into the 
lateral tail vein, using a 27 gauge needle. Mixed allogeneically reconstituted animals 
received 5 X 106 T cell-depleted syngeneic bone marrow cells and 1.5 x 10 7 T cell- 
depleted allogeneic bone marrow cells unless otherwise specified. Such animals will be 
referred to as mixed allogeneic himeras, mixed allogeneically reconstituted animals, or 
BI0 + B10.D2 ~ B10. Fully allogeneically reconstituted mice received 1.5 x 107 T cell- 
depleted allogeneic bone marrow cells (B10.D2 --~ B10). Syngeneically reconstituted 
controls received 5 x 10 6 T cell-depleted syngeneic bone marrow cells (B10 ~ B10). 
Radiation controls were performed simultaneously to confirm adequacy of the lethal 
radiation dose. 
Assays for Chimerism. Chimerism of peripheral blood lymphocytes (PBL) was assayed 
using a trypan blue exclusion microcytotoxicity est to determine the percentage of 
lymphocytes bearing host- or donor-type H-2 surface markers as previously described 
(11). Briefly, peripheral blood was collected into heparinized plastic serum vials. After 
thorough mixing, the suspension was diluted with 100 #1 of MEM plus 0.1% gelatin, and 
layered over a cold Ficoll-Hypaque gradient (Bionetics Laboratory Products, Charleston, 
SC). After centrifugation for 90 s in a Beckman microfuge, the lymphocyte layer was 
aspirated from the saline-Ficoll interface, and washed with MEM plus 0.1% gelatin. Red 
blood ceils were then ACK-lysed, and the remaining cells were washed and used in a 
trypan blue microcytotoxicity assay. 
Skin Grafting. Skin grafting was performed by a modification of the method of 
Billingham (12). Full-thickness tail skin grafts were harvested from the tails of B10.D2, 
B 10.BR, C3H/HeJ, and B10 mice. Mice were anesthetized with tribromoethanol injected 
intraperitoneally (13), and full-thickness defects were created surgically in the lateral 
thoracic wall. We were careful to preserve the panniculus carnosum. The grafts were 
covered with a double layer of vaseline gauze and a plaster cast. If more than one skin 
graft was placed on an animal, each defect for graft placement was separated by a 3-mm 
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skin bridge. Casts were removed on the eighth day. Grafts were scored daily for percent 
rejection, and rejection was considered complete when no residual viable graft was evident. 
Graft survivals were calculated by the life-table method (20), and the median survival time 
(MST) was derived from the time point at which 50% of grafts were surviving. 
Mixed Lymphocyte R actions (MLR). MLR were performed as previously described (14). 
Briefly, splenocytes were ACK-lysed, washed, and reconstituted in EHAA (NIH Media 
Unit, Bethesda, MD) supplemented with 0.75% fresh normal mouse serum, 0.09 mM 
nonessential mino acids, 1 mM sodium pyruvate, 2 mM glutamine, I00 U/ml penicillin, 
100 U/ml streptomycin, and 0.05 mM 2-mercaptoethanol. 4 x 105 responders were 
cultured with 4 x 105 stimulators (2,000-rad irradiated cells) and varying numbers of 
cocultured chimeric cells or normal control cells in a total of 200 or 250 #1 of media. 
Cultures were incubated at 37°C, 5% CO~ for 4 d, pulsed on the fourth day with 1 ~Ci 
[3H]thymidine (New England Nuclear, Boston, MA) and harvested on the fifth day with 
an automated harvester (Mash II; Microbiological Associates, Bethesda, MD). 
Cell-mediated Lympholysis (CML). CML assays were performed using a modification of 
techniques previously described (14, 15). Briefly, RPMI 1640 medium (Gibco) was 
supplemented as above, except that 10% fetal calf serum (Gibco) was used in place of 
normal mouse serum. 4 x 106 responders were cocultured with 4 x 106 stimulators 
(2,000-rad irradiated cells) and 2 x 10 6 o r  4 X 106 chimeric putative suppressor cells or 
normal control cells in 2 or 2.5 ml of medium at 37°C for 5 d. Mouse target blasts were 
stimulated with concanavalin A (Con A) (Miles-Yeda Laboratories, Inc., Israel) for 2 d. In 
some experiments, tumor targets were used. After 5 d, responders were harvested, 
counted, and resuspended atappropriate ffector/target ratios with 10451Cr-labeled blasts 
as targets. After 4.5 h, supernatants were harvested with the Titertek system, and specific 
lysis was calculated as follows: (experimental release - spontaneous release) X 100/ 
(maximal [HCI] release - machine background). Spontaneous release was <25% of 
maximum release unless otherwise indicated. 
Cellular depletions were performed on the chimeric cells to eliminate H-2 b- or H-2 d- 
bearing cells. Briefly, chimeric ells were incubated with B 10 anti-B 10.D2 sera or B 10.D2 
anti-B10 sera for 15 min at 37°C and 5% CO~ (5 x 106 cells per milliliter of antibody at 
1:20 dilution). Cells were washed and resuspended in screened, sterilely filtered rabbit 
complement (5 x 106 cells per milliliter of complement at 1:8 dilution in MEM) for 30 
min at 37°C. The suspension was then diluted with MEM and layered over warm 
Lympholyte M (Accurate Chemical Scientific Comp., Westbury, NY) in 50 ml conical 
tubes, and washed at 1,200 rpm for 25 min to separate viable from nonviable cells. The 
buffy coat was aspirated and washed twice in MEM (1,200 rpm for 10 rain). The cells 
were then resuspended in media for CML, counted, and the cell density adjusted to the 
appropriate concentration. Adequacy of depletions was determined by fluorescence- 
activated cell sorter using biotinylinated, protein-purified anti-H-2 b and anti-H-2 dmono- 
clonal antibodies and fluorescein isothiocyanate (FITC)-avidin fluorescent stain as previ- 
ously described (9, 16). 
Plaque-forming Cell (PFC) Assays. Sheep red blood cell (SRBC) PFC assays were 
performed as previously described (17). Briefly, animals were immunized intravenously 
with 0.2 ml of a 1% sheep red blood cell suspension on day 0. Partial splenectomies were 
performed on day 5, and titrated numbers of  spleen cells were assayed in triplicate for 
PFC responses. Values are expressed as plaques per 10 6 spleen cells. All experiments 
reported were recorded by an observer who had no knowledge of the identity of a given 
plate. 
Resu l ts  
Survival of Mice Reconstituted with Fully AUogeneic (BIO.D2 -~ BIO), Mixed 
Allogeneic (BIO + BIO.D2 ~ BIO), and Syngeneic (BIO ~ BIO) Bone Marrow 
Inocula. Survival o f  the mixed allogeneically reconst i tuted mice was excellent. 
Animals showed no evidence for GVHD or wasting. However ,  in our  special 
pathogen-f ree facility, long-term survival o f  our  fully al logeneic chimeras was 
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also excellent, and not significantly different from that for syngeneically (B10 ---* 
B10) reconstituted recipients (Fig. 1). To further assess in vivo immunocompe- 
tence by means of survival characteristics, age-matched animals from each of the 
following groups were moved from our special facility to a conventional facility 
6 mo after lethal irradiation and bone marrow reconstitution: (a) syngeneically 
reconstituted animals (B10 --* B10); (b) fully allogeneic chimeras (B10.D2 ---* 
B10); and (c) mixed allogeneic chimeras (B10 + B10.D2 ~ B10) (Fig. 2). 50-d 
survival after relocation was 40% for fully allogeneic chimeras, 80% for mixed 
allogeneic chimeras, and 83% for syngeneically reconstituted mice. Three rep- 
resentative mice that died were sent for serologic testing and animal autopsy, 
and were found to have died from endemic viral infections, including mouse 
20 
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FIGURE 1. Survival of  mixed allogeneic chimeras (B10 + B10.D2 ---* B10), fully allogeneic 
chimeras (B10.D2 ~ B10) and syngeneically reconstituted mice (B10 ~ BI0) in our specific 
pathogen-free facility, as calculated by the life table method. Minimum follow-up was 79 d. 
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FIGURE 2. Survival of  mice reconstituted with mixed allogeneic (B10 + B10.D2 ---* BI0), 
fully allogeneic (B10.D2 ~ B10), or syngeneic (B10 ~ B10) bone marrow inoculum in a 
conventional facility. Mice were moved to a conventional facility 6 mo after lethal irradiation 
and reconstitution; before this they had been housed in a specific pathogen-free facility. 
Survivals were calculated by the life table method. Animals were fol lowed for a minimum of 
90 d postrelocation. 
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hepatitis virus and Sendal virus. In addit ion, Citrobacter f eundii was isolated 
f rom the intestines o f  those animals. 
lmmunocompetence as Assessed by PFC Responses and Hemagglutination Assay. In 
an at tempt  o fur ther  assess in vivo immunocompetence  of  the mixed ai logeneic 
chimeras (B10 + B10.D2 --~ B10), animals were subjected to intravenous im- 
munizat ion with SRBC suspensions, and their ability to fo rm pr imary PFC 
responses quantitated. Mixed allogeneically reconst i tuted animals were found to 
be immunocompetent ,  with PFC responses similar to those of  syngeneically 
reconst i tuted (B10 ~ B10) mice. As seen in Fig. 3, fully al logeneic chimeras 
B 10.D2 ~ B 10) responded less well. These  data suggest hat the mixed allogeneic 
chimeras are able to recognize foreign antigens in the context  o f  self. 
Typing of Mixed Allogeneie Chimeras (BIO + BIO.D2 --~ BIO); Time Course of 
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FIGURE 3. Immunocompetence as assessed by primary PFC responses to in vivo immuniza- 
tion with SRBC. Responses are expressed as the geometric mean of plaques per 10 6 spleen 
cells ~ SEM. Syngeneic (B10 ---* B10) (n = 9), mixed allogeneic himeras (B10 + B10.D2 
B10) (n = 10), and fully allogeneic himeras (B10.D2 ~ B10) (n = 8) were tested. Normal 
(control) BI0 (n = 5). 
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Hematopoietic Repopulation. PBL typing of  the mixed allogeneically reconsti- 
tuted animals by trypan blue exclusion microcytotoxic ity assay revealed variable 
percentages of  donor - type lymphoid cells. Percentages of  ai logeneic lymphoid 
elements ranged f rom 5% to 95% in peripheral  blood. However ,  in all animals, 
donor - type elements were identified. The  time course of  reconst itut ion of  five 
fully al logeneic and five mixed allogeneic chimeras was fol lowed serially (Table 
I). A l though the absolute percentages of  donor- type lymphoid elements was seen 
to f luctuate over time, the animals all remained chimeric. 
Specific Tolerance to Donor-type Lymphoid Elements as Evidenced by MLR. As 
seen in a representat ive one-way MLR (Table II), mixed allogeneic chimeric 
responding ceils (B10 + B I0 .D2  ~ B10) were specifically unreact ive to donor  
(B10.D2) and host-type (B10) st imulator cells, while the response to third-party 
(B10.BR) cells was intact. 
The  response of  normal  control  B10 lymphocytes against B10.D2 splenocytes 
in coculture with chimeric cells has revealed no evidence for  specific or  nonspe- 
cific suppression f rom 3 wk to >1 yr after mixed allogeneic reconstitution. 
Exper iments included titration o f  increasing numbers  o f  cocul tured chimeric 
cells with 4 X 105 normal  B 10 lymphoid cells responding to B 10.D2 stimulators, 
as well as addit ion o f  chimeric cells to the reciprocal B 10.D2 anti-B 10 response. 
Specific Tolerance to Allogeneic Donor-type Lymphoid Elements as Evidenced by 
CML. Cells f rom the spleens of  mixed allogeneic chimeras (B10 + B10.D2 
B10) were examined for in vitro CML sensitization against B10, B10.D2, or 
TABLE I 
Characterization f Reconstitution f FuUy Allogeneic and Mixed Allogeneic Chimeras 
Reconstitution Animal number 
BI 0.D2 cells* at various weeks 
after reconstitution: 
1 2 3 5 48 
Fully allogeneic (B10.D2 --* B10) 
Mixed allogeneic (B10 + B10.D2 -* B10) 
% 
Normal B10 1 0 0 2 
Normal BI0.D2 99 100 96 98 99 
637 69 93 74 78 100 
638 80 100 100 78 100 
639 78 100 71 NT* NT 
640 81 100 100 79 92 
64l 84 96 100 100 100 
626 68 70 67 88 62 
627 71 72 80 61 84 
628 74 12 11 53 86 
629 68 90 84 82 100 
630 73 62 73 NT NT 
Complement-mediated cytotoxicity was performed on PBL by trypan blue exclusion microcytotox- 
icity assay. 
* Percentage of B10.D2 was calculated by normalizing the total percent specific kill by the two 
antisera used (anti-H-2 band anti-H-2 d) to 100%, after correction for percent lysis by complement 
(C) alone: [(percent B10.D2 - C)/(percent B10.D2 + percent B10) - 2(C)] x 100. 
* Animal not tested because of death or sacrifice. 
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TABLE II 
Host Hyporeactivity and Third-party Reactivity of Mixed Allogeneically Reconstituted Animals 
in One-way MLR (BIO + BIO.D2 --) BIO) 
Animal 
[SH]Thymidine uptake 
Anti-B 10 Anti-B 10. D2 Anti-B 10.BR 
cpm 
Normal B10 4,877 + 408 31,584 + 2,433 34,800 -+ 2,921 
Normal B10.D2 22,788 + 888 2,763 + 267 19,724 _ 729 
Chimera A 3,347 "4" 237 3,197 + 435 14,762 -+ 303 
Chimera B 2,725 + 292 2,427 + 456 11,600 +- 250 
Stimulation index 
Anti-B 10.D2 Anti-B 10.BR 
Normal BI0 6.5 7.1 
Normal BI0.D2 8.3 7.1 
Chimera A 0.9 4.3 
Chimera B 0.9 4.5 
Mean + SEM of  triplicate cultures at 1 : 1 responder/st imulator  ratio. Representative MLR illustrating 
the responses of  two individual animals. There  was little animal-to-animal variation. 
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F~C, URE 4. Skin allograft survival in mixed allogeneic himeras, as calculated by the life table 
method.  Skin grafts were followed for a min imum of 94 d. 
B10.BR stimulator cells in one-way CML. Corresponding cultures of chimeric 
responding cells produced no detectable cytotoxic effectors for host (B10)- or 
donor (B10.D2)-type Con A blast targets, but produced effectors capable of 
lysing B10.BR third-party blasts with an efficiency similar to that of nonirradiated 
control B 10 and B 10.D2 responders. In addition, chimeric lymphoid populations 
depleted of either H-2 b- or H-2d-bearing cells were specifically tolerant o host- 
and donor-type stimulator cells, but normally reactive to third-party cells (Fig. 
4). To test for the possibility of active suppression, ormal B 10 responding cells 
were cocultured with unirradiated spleen cells from chimeras, and B10.D2 or 
third-party B10.BR stimulators. In these experiments, no suppression of the B 10 
anti-B10.D2 response nor the B10 anti-B10.BR response could be detected, 
offering no evidence for specific or nonspecific suppression. 
238 MIXED ALLOGENE1C CHIMERAS 
Specific Tolerance to Allogeneic Donor-strain Skin Grafts in MHC-congenic Mixed 
Allogeneic Chimeras. Consistent with our previous findings (9), mixed allogene- 
ically reconstituted mice (B 10 + B 10.D2 ~ B 10) demonstrated specific tolerance 
to donor-type B10.D2 full-thickness tail skin grafts (MST >380 d) (Fig. 5). 
Rejection of  third-party allografts followed a time course similar to normal B10 
mice and syngeneically (B 10 ~ B 10) reconstituted recipients (MST = 14 d). All 
retained grafts were soft and appeared healthy, without evidence of  chronic 
rejection or inflammation, and they persisted in situ without contraction for the 
life span of  the animal. These findings were also extended to another mixed- 
MHC congenic combination (B10 + B10.BR ~ BI0), which likewise showed 
mixed chimerism and tolerence (Table III). 
Assessment of MHC-noncongenic Mixed Allogeneic Model; Skin Grafting, Chimerism, 
and Serologic Reactivity. To assess whether such complete acceptance of  skin 
grafts could be achieved in strains differing in both MHC and background, 
mixed allogeneic himeras (B 10 + C3H/HeJ  ~ B 10) were produced, and grafted 
with allogeneic donor-type (C3H; H-2 k) and third-party (B10.D2; H-2 d) skin 
grafts. In these animals, third-party skin grafts were rejected with a time course 
similar to unirradiated controls. The  donor-type skin grafts were accepted, and 
initially appeared soft and healthy; however, after -30  d the onset of induration 
was noted, and the grafts then followed a course consistent with prolonged 
chronic rejection. All grafts eventually contracted in size, and were considered 
rejected by 90 d (MST = 66 d) (Table III). Sera from two separate bleeds, taken 
Target: EL4IH 2 b) 
50 Stimulator: B10 
4O 
...I 
a~ 20 
10 
100:1 50:1 25:1 12.5:1 
EFFECTOR: TARGET RATIO 
5O 
co 40 
._J 
20 
10 
Target: P815 (H-2 d) 
100:1 50:1 25:1 12.5:1 
EFFECTOR: TARGET RATIO 
Target: RDM4 IH-2 k) 
Stirnutator: R10 BR 
- ~  0-0 Big 
H B10.D2 
Chimera 
IBm Chimera(H-2 b depleted) 
Chimera (H-2 d depleted) 
t]10 BR 
--O, ~ "5 ~- 
100:1 50:1 25:1 12.5:1 
EFFECTOR: TARGET RATIO 
FIGURE 5. Representative experiment of specific ytotoxic T lymphocyte lysis by mixed 
allogeneic chimeric splenocytes of CrS]-labeled target cells in one way CML to host, donor, 
and third-party targets. Spontaneous release was <25% unless otherwise indicated. B10 + 
B10.D2 --* B10 spleen cells were untreated (["l--U]), depleted of H-2 b- (11-----,), or H-2 d- 
([-I--[]) bearing cells by specific sera and tested in the assays. Efficacy of cellular depletions 
were confirmed by fluorescence-activated cell sorter using biotinylated protein-purified anti- 
H-2 b and anti-H-2 a monoc[onal ntibodies and FITC-avidin fluorescent s ain. 
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TABLE I I I  
Skin Graft Acceptance in MHC-congenic and MHC and Minor Disparate Strains 
239 
Reconstitution 
Skin graft survival 
Animal Th i rd  
num- Donor party* 
ber strain skin skin 
graft graft 
Median survival 
t ime 
Th i rd  
Donor 
party 
Mixed allogeneic 
MHC-congenic (BI0 + B10.BR --~ B10) 
Mixed allogeneic 
MHC-congenic (B10 + BI0.D2 --, B10) 
Mixed allogeneic (B10 + C3H --* B10) 
1 149* 14 >149 
2 149' 23 
3 149 ~ 19 
4 >250 14 >250 
5 >250 19 
6 >250 23 
7 >250 19 
8 66 19 66 
9 66 23 
10 88 23 
11 59 14 
12 90 11 
13 TF  11 
14 40 11 
15 88 11 
19 
19 
12.5 
* Th i rd  party was congenic B10.D2 or B10.BR. 
* Animal was sacrificed for in vitro cellular assays. 
death. 
Graft survival is recorded as intact up to date of  
from the animals at the time of most severe graft inflammation and rejection 
were not cytotoxic for C3H or B10.BR (H-2 k) target spleen cells by trypan blue 
cytotoxicity assay (data not shown). On day 70, these same animals were grafted 
with B10.BR skin grafts in order to assess the status of anti-MHC immunity. 
Such MHC-disparate congenic allografts were accepted, and have remained 
intact without evidence of acute or chronic inflammation for longer than 100 d. 
PBL typing of MHC-noncongenic allogeneic chimeras was carried out by 
trypan blue microcytotoxicity assay before the onset of chronic rejection of skin 
allografts, and at the height of the chronic rejection, or after rejection (Table 
IV). Although the percentages of C3H allogeneic ells detectable fluctuated, all 
animals remained mixed chimeras despite rejection of C3H skin grafts. 
Discussion 
Numerous tudies (8, 18, 19) have demonstrated that elimination of mature 
T cells from donor bone marrow inocula can lead to long-term survival of fully 
allogeneic radiation bone marrow chimeras in specific pathogen-free facilities. 
However, the survival of such animals is generally not as good as that of 
syngeneically reconstituted controls, and the health of the animals is often 
compromised, probably as a result of immunoincompetence due to a failure of 
appropriate immune cell interactions (6-8). These observations are especially 
true for animals housed in conventional facilities (6, 7), where survival has been 
reported to be very poor. In vitro studies of restriction by Singer et al. (8) have 
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TABLE IV 
Characterization f MHC-disparate Congenic and Noncongenic Mixed Allogeneic Chimeras 
111 d after 141 d after 
reconstitution reconstitution 
Animal H-2 k or Donor H-2 k or H-2 d Donor 
Reconstitution number H-2 d do- skin skin 
donor-type 
nor-type graft cells* graft 
cells* status* status* 
Normal BIO 
% % 
1 0 
Normal C3H 99 99 
Mixed allogeneic l 5 on 1 on 
MHC-congenic 2 l l on 73 (very on 
(B10 + B10.BR ---, Bt0) few cells) 
3 NT on 28 on 
(B10 + B10.D2 ~ B10) 4 64 on 25 on 
5 5 on 31 on 
6 74 on 70 on 
7 61 on 38 on 
8 27 on 63 off 
8 23 on 43 off 
10 44 on 42 on 
11 48 on 63 off 
12 85 on 91 on 
13 20 TF § 53 TF 
14 49 on 63 off 
15 44 on 50 on 
Mixed allogeneic MHC-noncon- 
genic (B10 + C3H ~ B10) 
* Percent H-2k-bearing lymphoid cells was calculated by normalizing the total percent specific kill by 
the two antisera used (anti-H-2 h and anti-H-2 k) to 100% after correction for percent lysis by 
complement (C) alone. [(Percent H-2 k - C)/(% H-2 k + % H-2 b) - 2(C)] × 100. Percent H-2 a- 
bearing allogeneic donor-type cells was calculated in a similar fashion for animals 4-7. 
* Animals were grafted 90 d after lethal irradiation and reconstitution with allogeneic donor-strain 
skin identical to bone marrow transplant. 
TF, technical failure. 
demonst ra ted  that  l ymphocytes  f rom ful ly a l logene ic  ch imeras  are  competent ,  
but  a re  apparent ly  res t r i c ted  to in teract ing  with accessory cells that  express  host, 
but  not  donor ,  MHC determinants .  In  these studies,  intact  sp leen cells f rom such 
ch imeras  were  not  capab le  o f  generat ing  responses  to t r in i t ropheno l -keyho le  
l impet  hemocyan in  (TNP-KLH)  unless  accessory cells o f  host  type were  added 
to in v i t ro  cu l tures ,  suppor t ing  the hypothes is  that  the immuno incompetence  
may be due  to a fa i lure  o f  appropr ia te  immune cell in teract ions  in these an imals .  
These  l imi tat ions  may be overcome by reconst i tu t ing  the mur ine  rec ip ient  
with a mix ture  o f  syngene ic  p lus a l logene ic  bone  marrow (8, 9). We hypothes ize  
that  the a l iogene ic  lympho id  component  prov ides  a mi l ieu  for  induct ion  o f  
specif ic t ransp lantat ion  to le rance  to the donor  stra in,  whi le the presence  o f  
syngene ic  lympho id  e lements  abrogates  the l imi tat ions  o f  immuno incompetence  
observed  in ful ly a l logene ic  h imeras  in v ivo and  in vitro.  
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The mixed allogeneically reconstituted mice (B10 + B10.D2 ~ B10) were 
found to be immunocompetent i  B cell and helper T cell function, as assessed 
by primary PFC responses to in vivo SRBC immunization. Their responses did 
not differ significantly from those of syngeneically (B10 ~ B10) reconstituted 
mice. This was in contrast to fully allogeneic himeras, the majority of which did 
not respond. Further evidence for the immunocompetence of such mixed allo- 
geneic chimeras is provided by their superior survival in a conventional nimal 
facility in comparison with fully allogeneic himeras, the majority of which 
succumbed to endemic viral infections. 
The mixed allogeneically reconstituted mice (B 10 + B 10.D2 ~ B 10) represent 
true mixed chimeras, bearing variable percentages of syngeneic and allogeneic 
lymphoid elements in their peripheral blood. Such chimerism has been main- 
tained for >48 wk after bone marrow transplantation. These findings are in 
contrast with our model for mixed xenogeneic reconstitution (B10 + F344 rat 
B10), where only low levels, if any, of donor-type lymphoid elements could 
be identified, despite acceptance of donor-type skin xenografts and specific in 
vitro tolerance to xenogeneic donor strain by MLR and CML (20). In addition, 
the percentage of allogeneic dohor-strain cells present in such mixed allogeneic 
chimeras did not appear to have an influence on the degree of tolerance to 
donor strain, as evidenced by specific skin graft acceptance and in vitro responses 
in CML and MLR. 
Despite reconstitution of the host with three times more allogeneic T cell- 
depleted bone marrow cells than identically treated syngeneic cells in the mixed 
allogeneic model, the animals manifested a variable range of mixed chimerism. 
The proportion of allogeneic donor-type (B10.D2) cells ranged from 5% to 95% 
in individual animals. 
In contrast with MHC-congenic mixed allogeneic himeras, in which the 
allogeneic (B10.D2, B10.BR) donor-strain skin allografts were specifically ac- 
cepted indefinitely, without evidence for chronic rejection donor-strain skin 
allografts from MHC-noncongenic mixed allogeneic himeras (B10 + C3H --~ 
B 10) underwent a chronic rejection reaction, with ultimate disappearance of the 
donor-type (C3H) skin graft. However, allogeneic donor-strain (C3H) lymphoid 
elements persisted in the hematopoietic system, despite rejection of the C3H 
skin grafts, and sera taken from the animals during the rejection process were 
not cytotoxic for C3H splenocytes. In addition, B10.BR skin grafts placed on 
those animals after rejection of the C3H (H-2 k) grafts were accepted indefinitely, 
without evidence of inflammation. This disparity of response to hematopoietic 
elements vs. skin allografts is most likely due to skin-specific alloantigens, perhaps 
similar to those characterized by Boyse et al. (21) and Steinmuller et al. (22). If 
so, subsequent survival of B 10.BR allografts indicates that such alloantigens must 
be encoded by genes outside the MHC. The appearance of prolonged chronic 
rejection with eventual slow contraction of the skin allografts and, ultimately, 
rejection, is reminiscent of the results we reported (20) in the mixed xenogeneic 
system (B10 + F344 rat ~ B10), suggesting that the ultimate rejection of skin 
grafts in this model may also have been due to skin-specific antigens. Studies are 
currently in progress to assess the in vitro reactivity of these MHC-noncongenic 
mixed allogeneic himeras. 
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Rejection of noncongenic skin grafts does not necessarily imply a problem for 
the adaptation of this model to transplantation of vascularized organs, since 
mismatching for non-MHC antigens does not appear to be of great significance 
for the outcome of renal allografts in man (23). In addition, skin-specific alloan- 
tigens may be among the few minor transplantation a tigens not also expressed 
on bone marrow cells. In this regard, Steinmuller and Lofgreen (22) reported 
acceptance of cardiac allografts in radiation bone marrow chimeras despite the 
rejection of donor-type skin grafts. Skin may indeed be the most difficult aliograft 
to prolong, and studies of vascularized grafts in this model are now in progress. 
Mixed allogeneic reconstitution may provide a model for investigation of the 
mechanisms of induction and maintenance of specific tolerance to allogeneic 
lymphoid elements. In addition, it may offer applications to the clinical bone 
marrow and solid organ transplantation setting. Conditioning of the host with 
single high-dose irradiation (or perhaps other suppressive regimens) and imme- 
diate mixed allogeneic bone marrow reconstitution coincident with solid organ 
transplantation could afford immediate use of donor organs with the potential 
for acceptance of the donor allograft in the absence of prolonged nonspecific 
chemical immunosuppressive agents. One major advantage of such mixed bone 
marrow reconstitution would be the ability to overcome the immunoincompe- 
tence observed in fully allogeneic himeras, while inducing and maintaining 
specific tolerance to the donor. Attempts to extend these studies to a large 
animal model are now progress. 
Summary 
Mixed allogeneically reconstituted mice (B 10 + B10.D2 --* B 10) that specifi- 
cally accept B10.D2 tail skin atlografts were examined for in vivo and in vitro 
immunocompetence, patterns of hematopoietic repopulation, and in vitro reac- 
tivity. In vitro, mixed allogeneic himeras (B10 + B10.D2 ~ B10) manifested 
specific tolerance in mixed lymphocyte reactions and cell-mediated lympholysis 
to B10 and B10.D2 splenocytes, with normal responses to third-party (B10.BR) 
cells. Such chimeras were immunocompetent in B cell and helper T cell responses, 
as assessed by their primary plaque forming cell responses to in vivo sheep red 
blood cell immunization. This is in contrast o fully altogeneic chimeras, which 
responded less well. In addition, survival of the mixed allogeneic himeras in a 
conventional nimal facility was superior to that of fully allogeneic himeras, and 
similar to syngeneically reconstituted (B10 --* B10) mice. Specific tolerance to 
skin grafts, degree of allogeneic engraftment, and persistence of chimerism was 
also assessed in a noncongenic mixed allogeneic ombination (B10 + C3H 
B 10). Such animals manifested specific hyporeactivity to C3H skin allografts, but 
eventual chronic rejection of the grafts occurred in spite of stable and persistent 
mixed chimerism. MHC-congenic (B 10.BR) skin grafts were accepted indefinitely 
in the same animals, suggesting that skin-specific non-major histocompatibility 
complex antigens were responsible for rejection of the C3H skin allografts. 
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